MHAT- Hristo Botev

Vratsa 3001

0 studies enrolling now · 2 studies all time

What they study most

Diabetes Mellitus, Type 2, Lymphocytic Leukemia, Chronic

Studies at this site

• Research Study to Compare Three Doses of Semaglutide Tablets Taken Once Daily in People With Type 2 Diabetes — Completed
• Comparison of the Treatments of Obinutuzumab + Venetoclax Versus Obinutuzumab + Chlorambucil in Patients With Chronic Lymphocytic Leukemia — Completed